Source: Eur Respir J, 53 (4) 1801736; 10.1183/13993003.01736-2018
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Lindsay Caldarone, Andrea Mariscal, Andrew Sage, Meraj Khan, Stephen Juvet, Tereza Martinu, Ricardo Zamel, Marcelo Cypel, Mingyao Liu, Nades Palaniyar, Shaf Keshavjee. Neutrophil extracellular traps in ex vivo lung perfusion perfusate predict the clinical outcome of lung transplant recipients. Eur Respir J, 53 (4) 1801736; 10.1183/13993003.01736-2018

Member's Comments

No comment yet.

Related content which might interest you: The lung in a box: ex vivo monitoring of donor lungs and clinical implications for lung preservation, repair and utilisation Source: Virtual Congress 2021 – Lung graft allocation and monitoring in the 21st century Year: 2021 Improving donor organ quality: the role of ex vivo lung perfusion Source: International Congress 2019 – ME2 Improving donor organ quality: the role of ex vivo lung perfusion Year: 2019 Ex vivo donor lung perfusion Source: School Course 2012 - Lung Transplantation Year: 2012 Exhaled NO measurements may be useful in assessing acute lung injury in donors and lung allograft recipients Source: Eur Respir J 2002; 20: Suppl. 38, 348s Year: 2002 Ex-vivo donor lung perfusion Source: ERS Course 2016 Year: 2016 Lung volumes predict survival in patients with chronic lung allograft dysfunction Source: Eur Respir J , 49 (4)  1601315; DOI: 10.1183/13993003.01315-2016 Year: 2017 Pathogen-induced activation of human alveolar macrophages from lung transplant recipients Source: Annual Congress 2004 - Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury: lessons learnt from lung transplantation Year: 2004 Potential therapeutic targets for lung repair during human ex vivo lung perfusion Source: Eur Respir J, 55 (4) 1902222; 10.1183/13993003.02222-2019 Year: 2020 Oxygenated hemoglobin predicts outcome in patients with chronic lung allograft dysfunction Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 PP231 – Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF Source: ERS Lung Science Conference 2021 Year: 2021 Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021 Intracellular cytokines in blood T cells and monocytes in lung transplant patients - potential utility in monitoring immunosuppression protocols Source: Eur Respir J 2004; 24: Suppl. 48, 452s Year: 2004 Intra-alveolar neutrophil-derived microvesicles predict development of primary graft dysfunction after lung transplantation. Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020 Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation Source: Annual Congress 2012 - Novel approaches to lung transplantation Year: 2012 Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo Source: Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016 Year: 2017 Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 The effect of everolimus on lung function and renal status in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010